相关实验视频
Updated: Jul 26, 2025
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
37.7K
基因模型的开发与机器学习技术相结合,可以预测先进的动脉样硬化斑块
Lufeng Wang1, Yiwen Bao1, Fei Yu1
1Department of Neurology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Clinical neurology and neurosurgery
|June 14, 2023
概括
这项研究开发了一种新的遗传和机器学习模型,用于预测晚期动脉样硬化,这是中风的主要原因. 该模型表现出强大的预测能力,识别了心血管疾病风险的关键基因特征.
科学领域:
- 心血管研究研究心血管研究
- 生物信息学是一种生物信息学.
- 基因组学就是基因组学.
背景情况:
- 动脉样硬化是全球主要的死亡原因,主要是中风.
- 大动脉中的高级动脉样硬化斑块破裂,如动脉,导致严重的心血管事件.
- 识别晚期动脉样硬化遗传标记对于风险预测和预防至关重要.
研究的目的:
- 利用遗传数据和机器学习,开发先进动脉样硬化斑块的预测模型.
- 识别与晚期动脉样硬化相关的关键基因特征.
- 在独立的数据集中验证预测模型的性能.
主要方法:
- 利用微阵列数据集 (GSE28829,GSE43292) 来识别差异表达基因 (DEG).
- 应用随机森林 (RF) 算法来选前30个预测基因,并开发了一个"基因分数".
- 构建了一个人工神经网络 (ANN) 模型用于斑块预测,在GSE104140.0上得到验证.
主要成果:
- 确定了176种在免疫和炎症途径中丰富的DEG.
- 射频算法为预测模型选择了30个关键基因 (25个上调,5个下调).
- 该ANN模型实现了高预测准确性 (AUC=0.913在训练中,AUC=0.827在验证中).
结论:
- 通过生物信息学和机器学习成功建立了先进动脉样硬化斑块的强大预测模型.
- 这项研究开创了结合生物信息学和机器学习的应用,用于预测晚期动脉样硬化.
- 需要进一步的研究来验证已识别的基因特征和模型的临床实用性.
相关概念视频
01:30Atherosclerosis I: Introduction
13
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
16
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
16
01:26Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15